Dow Jones Newswire ( 11/6 http://tinyurl.com/generic-lamictal) reports, “Aurobindo Pharma Ltd. said Friday it has received the final approval from the US Food and Drug Administration for selling a generic version of the epilepsy” medication lamotrigine [Lamictal]. The FDA approval “is for 5-milligram and 25-mg tablets.” GlaxoSmithKline manufactures the brand name version of the medication.
FDA approves generic version of lamotrigine.
November 8, 2009 by abrandemihl
Leave a Reply